Related references
Note: Only part of the references are listed.Pharmacological characterization and chemical fractionation of a liposterolic extract of saw palmetto (Serenoa repens): Effects on rat prostate contractility
Thiam Chua et al.
JOURNAL OF ETHNOPHARMACOLOGY (2014)
Inhibitors of apoptosis proteins in experimental benign prostatic hyperplasia: effects of serenoa repens, selenium and lycopene
Letteria Minutoli et al.
JOURNAL OF BIOMEDICAL SCIENCE (2014)
Comparative Evaluation of the Efficiency of Prostatotropic Agents of Natural Origin in Experimental Benign Prostatic Hyperplasia
T. G. Borovskaya et al.
BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE (2013)
A phase II randomised double-blind placebo-controlled clinical trial investigating the efficacy and safety of ProstateEZE Max: A herbal medicine preparation for the management of symptoms of benign prostatic hypertrophy
Samantha Coulson et al.
COMPLEMENTARY THERAPIES IN MEDICINE (2013)
EAU Guidelines on the Treatment and Follow-up of Non-neurogenic Male Lower Urinary Tract Symptoms Including Benign Prostatic Obstruction
Matthias Oelke et al.
EUROPEAN UROLOGY (2013)
Lipidosterolic Extract of Serenoa Repens Modulates the Expression of Inflammation Related-Genes in Benign Prostatic Hyperplasia Epithelial and Stromal Cells
Nanor Sirab et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2013)
Effect of Serenoa repens (Permixon®) on the expression of inflammation-related genes: analysis in primary cell cultures of human prostate carcinoma
Ida Silvestri et al.
JOURNAL OF INFLAMMATION-LONDON (2013)
Improving BPH symptoms and sexual dysfunctions with a saw palmetto preparation? Results from a pilot trial
Andreas Suter et al.
PHYTOTHERAPY RESEARCH (2013)
Effects of Serenoa Repens, Selenium and Lycopene (Profluss®) on chronic inflammation associated with Benign Prostatic Hyperplasia: results of FLOG (Flogosis and Profluss in Prostatic and Genital Disease), a multicentre Italian study
Giuseppe Morgia et al.
INTERNATIONAL BRAZ J UROL (2013)
Hexanic lipidosterolic extract of Serenoa repens inhibits the expression of two key inflammatory mediators, MCP-1/CCL2 and VCAM-1, in vitro
Alain Latil et al.
BJU INTERNATIONAL (2012)
Serenoa repens monotherapy for benign prostatic hyperplasia (BPH): an updated Cochrane systematic review
Roderick MacDonald et al.
BJU INTERNATIONAL (2012)
Intensification of extraction of natural products using ultrasonic irradiations A review of current status
S. R. Shirsath et al.
CHEMICAL ENGINEERING AND PROCESSING-PROCESS INTENSIFICATION (2012)
The Correlation Between Metabolic Syndrome and Prostatic Diseases
Cosimo De Nunzio et al.
EUROPEAN UROLOGY (2012)
Isolation of essential oil from different plants and herbs by supercritical fluid extraction
Tiziana Fornari et al.
JOURNAL OF CHROMATOGRAPHY A (2012)
Application of ionic liquid for extraction and separation of bioactive compounds from plants
Baokun Tang et al.
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES (2012)
Applications of Supercritical Fluid Extraction (SFE) of Palm Oil and Oil from Natural Sources
Mohammed Jahurul Haque Akanda et al.
MOLECULES (2012)
Androgen-independent Effects of Serenoa repens Extract (Prostasan®) on Prostatic Epithelial Cell Proliferation and Inflammation
Diego Iglesias-Gato et al.
PHYTOTHERAPY RESEARCH (2012)
Enzyme-assisted extraction of bioactives from plants
Munish Puri et al.
TRENDS IN BIOTECHNOLOGY (2012)
Pressurized liquid extraction as a green approach in food and herbal plants extraction: A review
Arwa Mustafa et al.
ANALYTICA CHIMICA ACTA (2011)
Microwave-assisted extractions of active ingredients from plants
Chung-Hung Chan et al.
JOURNAL OF CHROMATOGRAPHY A (2011)
Microwave assisted extraction of secondary metabolites from plants: Current status and future directions
Hua-Feng Zhang et al.
TRENDS IN FOOD SCIENCE & TECHNOLOGY (2011)
Serenoa repens extract in the treatment of benign prostatic hyperplasia
Petrisor Geavlete et al.
THERAPEUTIC ADVANCES IN UROLOGY (2011)
A Widespread Population Study of Actual Medical Management of Lower Urinary Tract Symptoms Related to Benign Prostatic Hyperplasia Across Europe and Beyond Official Clinical Guidelines
Jean-Nicolas Cornu et al.
EUROPEAN UROLOGY (2010)
Isolation and Pharmacological Characterization of Fatty Acids from Saw Palmetto Extract
Masayuki Abe et al.
ANALYTICAL SCIENCES (2009)
Characterizing components of the Saw Palmetto Berry Extract (SPBE) on prostate cancer cell growth and traction
Carina Scholtysek et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2009)
Pharmacologically Relevant Receptor Binding Characteristics and 5α-Reductase Inhibitory Activity of Free Fatty Acids Contained in Saw Palmetto Extract
Masayuki Abe et al.
BIOLOGICAL & PHARMACEUTICAL BULLETIN (2009)
Serenoa repens extract targets mitochondria and activates the intrinsic apoptotic pathway in human prostate cancer cells
Antonella Baron et al.
BJU INTERNATIONAL (2009)
Lipido-Sterolic Extract of Serenoa repens (LSESr, Permixon®) Treatment Affects Human Prostate Cancer Cell Membrane Organization
E. Petrangeli et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2009)
Development of saw palmetto (Serenoa repens) fruit and extract standard reference materials
Michele M. Schantz et al.
ANALYTICAL AND BIOANALYTICAL CHEMISTRY (2008)
Profile and management of patients treated for the first time for lower urinary tract symptoms/benign prostatic hyperplasia in four European countries
Richard-Olivier Fourcade et al.
BJU INTERNATIONAL (2008)
Comparison of the Potency of Different Brands of Serenoa Repens Extract on 5 alpha-Reductase Types I and II in Prostatic Co-Cultured Epithelial and Fibroblast Cells
Francesco Scaglione et al.
PHARMACOLOGY (2008)
Not all brands are created equal:: a comparison of selected components of different brands of Serenoa repens extract
FK Habib et al.
PROSTATE CANCER AND PROSTATIC DISEASES (2004)
Is there a scientific basis for the therapeutic effects of serenoa repens in benign prostatic hyperplasia? Mechanisms of action
AC Buck
JOURNAL OF UROLOGY (2004)
Inhibition of type 1 and type 2 5α-reductase activity by free fatty acids, active ingredients of permixon®
JP Raynaud et al.
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2002)
Phytotherapy in the management of benign prostatic hyperplasia
FC Lowe
UROLOGY (2001)
Share Paper
